Erudio Healtherudio.com
Sponsor
Hansoh Pharma trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Hansoh Pharma yet. Erudio has found public clinician commentary on 5 clinical trials sponsored by Hansoh Pharma, including AENEAS2, ARTEMIS-001, ARTEMIS-008 and ARTEMIS-011. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Hansoh BioMedical R&D Company; Jiangsu Hansoh Pharmaceutical Co., Ltd.; Shanghai Hansoh Biomedical Co., Ltd). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ARTEMIS-008 NCT06498479 · Hansoh BioMedical R&D Company DeepView → | relapsed small cell lung cancer | Phase 3 | Deep | View | |||
| ARTEMIS-011 NCT06935409 · Hansoh BioMedical R&D Company DeepView → | osteosarcoma after second-line treatment failure | Phase 3 | Deep | View | |||
| AENEAS2 NCT04923906 · Jiangsu Hansoh Pharmaceutical Co., Ltd. StandardView → | EGFR-mutated advanced non-small-cell lung cancer | Phase 3 | Standard | View | |||
| ARTEMIS-001 NCT05276609 · Shanghai Hansoh Biomedical Co., Ltd StandardView → | locally advanced or metastatic solid tumors | Phase 1 | Standard | View | |||
| HS-10241-301 NCT06110663 · Jiangsu Hansoh Pharmaceutical Co., Ltd. FocusedView → | advanced NSCLC with EGFR-TKI resistance and MET amplification | Phase 3 | Focused | View | |||